Detalles de la búsqueda
1.
Pirtobrutinib versus venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Haematologica
; 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38031799
2.
Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysis.
Oncologist
; 27(5): 371-379, 2022 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35522557
3.
Patient-Reported Outcomes with Selpercatinib Among Patients with RET Fusion-Positive Non-Small Cell Lung Cancer in the Phase I/II LIBRETTO-001 Trial.
Oncologist
; 27(1): 22-29, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34523767
4.
Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 Trial.
Oncologist
; 27(1): 13-21, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516023
5.
Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma.
Future Oncol
; 18(33): 3727-3740, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36377818
6.
Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study.
Future Oncol
; 17(14): 1777-1791, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33590772
7.
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2.
Liver Int
; 40(8): 2008-2020, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32279446
8.
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis.
BMC Cancer
; 19(1): 353, 2019 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30987609
9.
Association between life-course socioeconomic position and inflammatory biomarkers in older age: a nationally representative cohort study in Taiwan.
BMC Geriatr
; 17(1): 201, 2017 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28865434
10.
Real-world clinical profile, RET mutation testing, treatments, and PROs for MTC in Europe.
Eur Thyroid J
; 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38189657
11.
Bayesian survival extrapolation for cost-effectiveness analysis: a case study of RELAY for ramucirumab in combination with erlotinib in the treatment of non-small-cell lung cancer.
J Med Econ
; 26(1): 1479-1488, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38035666
12.
Optimizing the Dosing Regimen of Cetuximab and Ramucirumab Using the Model-Informed Drug Development Paradigm.
Clin Pharmacol Ther
; 114(1): 77-87, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37087634
13.
Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY Study.
Target Oncol
; 18(4): 505-515, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37329423
14.
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001.
Cancers (Basel)
; 16(1)2023 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201566
15.
Admission rates and in-hospital mortality for hip fractures in England 1998 to 2009: time trends study.
J Public Health (Oxf)
; 33(2): 284-91, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20926392
16.
Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial.
Clin Drug Investig
; 41(1): 53-64, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33355909
17.
KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis.
Cancer Treat Res Commun
; 24: 100200, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750661
18.
Global variations in health: evaluating Wilkinson's income inequality hypothesis using the World Values Survey.
Soc Sci Med
; 68(4): 643-53, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19095338
19.
Compositional and contextual approaches to the study of health behaviour and outcomes: using multi-level modelling to evaluate Wilkinson's income inequality hypothesis.
Health Place
; 15(1): 198-203, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18514014
20.
Is ramucirumab and paclitaxel therapy beneficial for second-line treatment of metastatic gastric or junctional adenocarcinoma for patients with ascites? Analysis of RAINBOW phase 3 trial data.
Cancer Manag Res
; 11: 2261-2267, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30962715